Abolaji Samson Olagunju
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Abolaji Samson Olagunju has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- John Oluwafemi Teibo
University of São Paulo
4 shared publications - Gustavo Pessini Amarante-Mendes
Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo
3 shared publications Abiola Adeyanju Alagbe
Department of Human Anatomy, University of Port Harcourt, Nigeria
2 shared publications- Olabode Omotoso
University of Ibadan
2 shared publications Titilayomi Ayomide Otenaike
Department of Genetics and Molecular Biology, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil
2 shared publications- Abiodun M. Adewolu
Department of Biochemistry, College of Medicine, University of Lagos, Nigeria
1 shared publication
Latest Publications
- Open Access
- 14 March 2026
- Published by Elsevier in Scientific African
Bioactive compounds and Pharmacological properties of Portulaca oleracea
- 14 March 2026
- Published by Elsevier in Scientific African
Open AccessBioactive compounds and Pharmacological properties of Portulaca oleracea
- Open Access
- 31 July 2025
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (7) , 36329
Memory T Cells, Recombinant Listeria monocytogenes, and Cancer Vaccines
Memory T cells are essential for effective and durable immune responses, as they provide long-term immunological surveillance and rapid reactivity upon re-exposure to a given pathogen or cancer cell. In solid tumors, the immunosuppressive tumor microenvironment (TME) often hinders immune activation, making enhancing memory T cell formation and persistence a key goal in cancer immunotherapy. Novel strategies are exploring ways to support these memory T cells, including using Listeria monocytogenes as a cancer vaccine vector. Notably, L. monocytogenes has unique properties that make it an ideal candidate for this purpose: it is highly effective at activating T cells, promoting the differentiation and survival of memory T cells, and modulating the TME to favor immune cell function. Thus, by leveraging the ability of L. monocytogenes to induce a strong, sustained T-cell response, researchers aim to develop vaccines that provide lasting immunity against tumors, reduce recurrence rates, and improve patient survival outcomes. This mini-review highlights the potential of memory T cell-focused cancer immunotherapy and the promising role of L. monocytogenes in advancing these efforts.
- 31 July 2025
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (7) , 36329
Open AccessMemory T Cells, Recombinant Listeria monocytogenes, and Cancer Vaccines
Memory T cells are essential for effective and durable immune responses, as they provide long-term immunological surveillance and rapid reactivity upon re-exposure to a given pathogen or cancer cell. In solid tumors, the immunosuppressive tumor microenvironment (TME) often hinders immune activation, making enhancing memory T cell formation and persistence a key goal in cancer immunotherapy. Novel strategies are exploring ways to support these memory T cells, including using Listeria monocytogenes as a cancer vaccine vector. Notably, L. monocytogenes has unique properties that make it an ideal candidate for this purpose: it is highly effective at activating T cells, promoting the differentiation and survival of memory T cells, and modulating the TME to favor immune cell function. Thus, by leveraging the ability of L. monocytogenes to induce a strong, sustained T-cell response, researchers aim to develop vaccines that provide lasting immunity against tumors, reduce recurrence rates, and improve patient survival outcomes. This mini-review highlights the potential of memory T cell-focused cancer immunotherapy and the promising role of L. monocytogenes in advancing these efforts.
- Open Access
- 8 July 2025
- Published by Rasayely in International Journal of Equine Science
- Vol. 4 (2) , 199-213
The Effect of Physical Activity on Cytokine Production: A Systematic Parallel Study of Horse and Human Athletes
Cytokines are glycoproteins responsible for cellular communication, influenced by exercise. Their levels vary depending on the intensity and type of physical activity in both humans and horses. This review aimed to assess the effects of various types and intensities of exercise on the production of pro- and anti-inflammatory cytokines. A systematic search (2000–2022) was performed using databases such as PubMed, Scopus, and Web of Science. Studies involving horses (n = 3) and/or humans (n = 21) undergoing physical activity were selected, resulting in 24 eligible articles. IL-6, TNF-α, and IL-10 levels increased after high-intensity exercise in both species, while moderate-intensity activity yielded more variable results. Some cytokines, such as IL-1β and IL-17, exhibited species-specific differences. Cytokine production is influenced by exercise intensity and duration. The observed differences between horses and humans suggest physiological divergences, warranting further research in the field of exercise immunology and other related disciplines. As a potential outcome of this work, we propose that horses could serve as an appropriate translational animal model for human athletes in exercise immunology, justifying a more comprehensive comparative approach.
- 8 July 2025
- Published by Rasayely in International Journal of Equine Science
- Vol. 4 (2) , 199-213
Open AccessThe Effect of Physical Activity on Cytokine Production: A Systematic Parallel Study of Horse and Human Athletes
Cytokines are glycoproteins responsible for cellular communication, influenced by exercise. Their levels vary depending on the intensity and type of physical activity in both humans and horses. This review aimed to assess the effects of various types and intensities of exercise on the production of pro- and anti-inflammatory cytokines. A systematic search (2000–2022) was performed using databases such as PubMed, Scopus, and Web of Science. Studies involving horses (n = 3) and/or humans (n = 21) undergoing physical activity were selected, resulting in 24 eligible articles. IL-6, TNF-α, and IL-10 levels increased after high-intensity exercise in both species, while moderate-intensity activity yielded more variable results. Some cytokines, such as IL-1β and IL-17, exhibited species-specific differences. Cytokine production is influenced by exercise intensity and duration. The observed differences between horses and humans suggest physiological divergences, warranting further research in the field of exercise immunology and other related disciplines. As a potential outcome of this work, we propose that horses could serve as an appropriate translational animal model for human athletes in exercise immunology, justifying a more comprehensive comparative approach.
- 23 October 2024
- Published by Wiley in Immunology & Cell Biology
- Vol. 103 (1) , 19-21
Strive, Thrive & Survive: embracing challenges in pursuit of passion
Challenges don’t last; embracing them is crucial to growth and success. Knowing and absorbing this is very important for students in any program and at any level in the academic world. I have my bachelor’s and master’s degrees from Ladoke Akintola University of Technology and University of Ibadan, Nigeria, respectively. Currently, I am a doctorate student at the Department of Immunology, University of Sao Paulo, Brazil. This article discusses my adaptation to a new environment, overcoming challenges, and the importance of support systems.
- 23 October 2024
- Published by Wiley in Immunology & Cell Biology
- Vol. 103 (1) , 19-21
Strive, Thrive & Survive: embracing challenges in pursuit of passion
Challenges don’t last; embracing them is crucial to growth and success. Knowing and absorbing this is very important for students in any program and at any level in the academic world. I have my bachelor’s and master’s degrees from Ladoke Akintola University of Technology and University of Ibadan, Nigeria, respectively. Currently, I am a doctorate student at the Department of Immunology, University of Sao Paulo, Brazil. This article discusses my adaptation to a new environment, overcoming challenges, and the importance of support systems.
- Open Access
Long-Lasting, Fine-Tuned Anti-Tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules
One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria monocytogenes, have been shown to elicit a robust in vivo CD8+ T-cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host’s response to Listeria-based vectors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hypothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vaccinate wild-type (WT), caspase-1/11−/−, gsdmd−/−, ripk3−/−, and mlkl−/− C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminating target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with the B16F0 and B16F0.OVA melanoma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies interfere with the rapid control of LM.OVA infection, neither of the KOs seems to contribute to the early activation of OVA-specific CTL responses. In contrast, the individual deficiency of each one of these proteins positively impacts the generation of long-lasting effector CD8+ T cells.
Open AccessLong-Lasting, Fine-Tuned Anti-Tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules
One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria monocytogenes, have been shown to elicit a robust in vivo CD8+ T-cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host’s response to Listeria-based vectors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hypothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vaccinate wild-type (WT), caspase-1/11−/−, gsdmd−/−, ripk3−/−, and mlkl−/− C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminating target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with the B16F0 and B16F0.OVA melanoma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies interfere with the rapid control of LM.OVA infection, neither of the KOs seems to contribute to the early activation of OVA-specific CTL responses. In contrast, the individual deficiency of each one of these proteins positively impacts the generation of long-lasting effector CD8+ T cells.
- Open Access
- 1 September 2024
- Published by Wiley
not-yet-known not-yet-known not-yet-known unknown Strive, Thrive, & Survive: Embracing Challenges in Pursuit of Passion
Challenges don’t last; embracing them is crucial to growth and success. Knowing and absorbing this, is very important for students in any program and at any level in the academic world. This article discussed my adaptation to a new environment, overcoming challenges, and the importance of support systems.
- 1 September 2024
- Published by Wiley
Open Accessnot-yet-known not-yet-known not-yet-known unknown Strive, Thrive, & Survive: Embracing Challenges in Pursuit of Passion
Challenges don’t last; embracing them is crucial to growth and success. Knowing and absorbing this, is very important for students in any program and at any level in the academic world. This article discussed my adaptation to a new environment, overcoming challenges, and the importance of support systems.
- Open Access
- 13 August 2024
- Published by MDPI AG in Preprints.org
Long-Lasting, Fine-Tuned Anti-tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules
One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria mono-cytogenes, have been shown to elicit a robust in vivo CD8+ T cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host's response to Listeria-based vec-tors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hy-pothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vac-cinate wild-type (WT), caspase-1/11-/-, gsdmd-/-, ripk3-/-, and mlkl-/- C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminat-ing target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with B16F0 and B16F0.OVA mela-noma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies in-terfere with the rapid control LM.OVA infection, of the KO seems to contribute to the early acti-vation of OVA-specific CTL responses. In contrast, individual deficiency of each one of these pro-teins negatively impact the generation of long-lasting effector CD8+ T cells.
- 13 August 2024
- Published by MDPI AG in Preprints.org
Open AccessLong-Lasting, Fine-Tuned Anti-tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules
One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria mono-cytogenes, have been shown to elicit a robust in vivo CD8+ T cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host's response to Listeria-based vec-tors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hy-pothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vac-cinate wild-type (WT), caspase-1/11-/-, gsdmd-/-, ripk3-/-, and mlkl-/- C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminat-ing target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with B16F0 and B16F0.OVA mela-noma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies in-terfere with the rapid control LM.OVA infection, of the KO seems to contribute to the early acti-vation of OVA-specific CTL responses. In contrast, individual deficiency of each one of these pro-teins negatively impact the generation of long-lasting effector CD8+ T cells.
- Open Access
Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
- Open Access
- 28 August 2022
- Published by Elsevier in Scientific African
- Vol. 17
Recent developments in the significant effect of mRNA modification (M6A) in glioblastoma and esophageal cancer
- 28 August 2022
- Published by Elsevier in Scientific African
- Vol. 17
Open AccessRecent developments in the significant effect of mRNA modification (M6A) in glioblastoma and esophageal cancer
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Mitochondrial Dysfunction: A Notable Contributor to the Progression of Alzheimer's and Parkinson's Disease
Mitochondrial dysfunctions remained a pivotal mechanism in manifold neurodegenerative diseases. Mitochondrial homeostasis within the cell is an essential aspect of cell biology. Mitochondria which is also known as the power-generating set of the cell, have a dominant role in several processes associated with the genomic integrity and cellular equilibrium maintenance. They are involved in maintaining optimal cells functioning and guidance from possible DNA damage which could lead to mutations and onset of diseases. Conversely, system perturbations which could be due to environmental factors or senescence induce changes in the physiological balance and result in the mitochondrial functions impairment. Funding Statement: The project received no fund either from governmental or non-governmental organization. The project is self-funded by all authors. Declaration of Interests: The authors declare that they have no competing interests
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessMitochondrial Dysfunction: A Notable Contributor to the Progression of Alzheimer's and Parkinson's Disease
Mitochondrial dysfunctions remained a pivotal mechanism in manifold neurodegenerative diseases. Mitochondrial homeostasis within the cell is an essential aspect of cell biology. Mitochondria which is also known as the power-generating set of the cell, have a dominant role in several processes associated with the genomic integrity and cellular equilibrium maintenance. They are involved in maintaining optimal cells functioning and guidance from possible DNA damage which could lead to mutations and onset of diseases. Conversely, system perturbations which could be due to environmental factors or senescence induce changes in the physiological balance and result in the mitochondrial functions impairment. Funding Statement: The project received no fund either from governmental or non-governmental organization. The project is self-funded by all authors. Declaration of Interests: The authors declare that they have no competing interests